Published in Int J Radiat Oncol Biol Phys on September 01, 2000
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer (2005) 1.68
Choline PET based dose-painting in prostate cancer--modelling of dose effects. Radiat Oncol (2010) 0.94
70 Gy or more: which dose for which prostate cancer? J Cancer Res Clin Oncol (2005) 0.86
Localized prostate cancer treated with external beam radiation therapy: Long-term outcomes at a European comprehensive cancer centre. Rep Pract Oncol Radiother (2016) 0.81
The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning. Onco Targets Ther (2016) 0.75
HUMAN TOXOPLASMOSIS: OCCURRENCE IN INFANTS AS AN ENCEPHALOMYELITIS VERIFICATION BY TRANSMISSION TO ANIMALS. Science (1939) 7.95
Toxoplasmic encephalomyelitis: III. A new case of granulomatous encephalomyelitis due to a protozoon. Am J Pathol (1939) 7.25
Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med (1974) 3.03
Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol (1997) 2.20
Granular cell tumors of the central nervous system. J Neuropathol Exp Neurol (1973) 1.79
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol (2005) 1.70
Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys (1998) 1.70
Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest (1997) 1.65
FETAL ENCEPHALOMYELITIS: PRENATAL INCEPTION OF INFANTILE TOXOPLASMOSIS. Science (1941) 1.51
Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol (2004) 1.47
Influence of tumoral, radiobiological, and general factors on local control and survival of a series of 361 tumors of the velotonsillar area treated by exclusive irradiation (external beam irradiation+brachytherapy or brachytherapy alone) Int J Radiat Oncol Biol Phys (1994) 1.44
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]. Cancer Radiother (2002) 1.39
[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]. Cancer Radiother (2013) 1.39
[Treatment of lung cancer in the elderly]. Rev Mal Respir (2004) 1.39
[Treatment of bronchial carcinoma in the elderly]. Rev Mal Respir (2002) 1.37
Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys (1997) 1.30
Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer (1999) 1.26
Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer (2004) 1.21
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer (2001) 1.18
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol (2009) 1.18
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer (2012) 1.17
Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys (1994) 1.15
Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy. Prostate (1999) 1.14
Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer (2005) 1.12
Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys (2000) 1.10
Spinal cord compression by secondary epi- and intradural metastases in childhood. Childs Nerv Syst (1997) 1.06
Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol (2006) 1.03
Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality. Int J Epidemiol (2000) 1.01
Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. N Engl J Med (1984) 1.01
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol (2001) 1.01
Detection of errors in individual patients in radiotherapy by systematic in vivo dosimetry. Radiother Oncol (1995) 1.00
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results. Ann Oncol (2005) 0.98
Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies. Int J Radiat Oncol Biol Phys (2000) 0.97
Esophageal cancer: determination of internal target volume for conformal radiotherapy. Radiother Oncol (2006) 0.96
[Natural history and development of bone metastasis. Apropos of 429 cases]. Bull Cancer (1988) 0.95
The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies. Br J Cancer (1998) 0.94
Desmoplastic small round cell tumors of the abdomen. Cancer (1994) 0.94
Neuropathological changes in Chédiak-Higashi disease. J Neuropathol Exp Neurol (1969) 0.94
Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results. Int J Radiat Oncol Biol Phys (2000) 0.94
Quantitative scale of oral mucositis associated with autologous bone marrow transplantation. Eur J Cancer B Oral Oncol (1996) 0.93
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. Eur J Cancer (2009) 0.93
[Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications]. Cancer Radiother (2010) 0.92
Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy. Radiother Oncol (1994) 0.92
A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol (1997) 0.91
Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol (1992) 0.91
Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiother Oncol (2009) 0.90
French version of FACT-G: validation and comparison with other cancer-specific instruments. Eur J Cancer (2004) 0.89
Brachytherapy for lower lip epidermoid cancer: tumoral and treatment factors influencing recurrences and complications. Radiother Oncol (1994) 0.89
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014). Eur J Cancer (2009) 0.89
The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys (1994) 0.89
[Our experience with Colonna's operation in the treatment of congenital dislocation of the hip in children. Results of 69 operations followed for more than 2 years]. Rev Chir Orthop Reparatrice Appar Mot (1973) 0.88
Encephalopathy associated with carcinoma. Trans Am Neurol Assoc (1965) 0.88
Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation. Radiother Oncol (2000) 0.88
Homocystinuria. Arch Neurol (1965) 0.88
Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE. Ann Oncol (2012) 0.88
[Axillary lymphoceles after breast cancer surgery. Pathogeny, prevention]. J Chir (Paris) (1996) 0.88
Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach. Eur J Cancer (2012) 0.87
Brain metastases in children with solid tumors. Cancer (1997) 0.87
Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation. Int J Radiat Oncol Biol Phys (2000) 0.87
Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol (1994) 0.87
Acinic cell carcinoma of the parotid gland with skull base invasion: case study, managed by exclusive external 3D radiation therapy. Eur Ann Otorhinolaryngol Head Neck Dis (2011) 0.87
[CyberKnife robotic stereotactic radiotherapy: technical aspects and medical indications]. Cancer Radiother (2007) 0.86
Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume. Int J Radiat Oncol Biol Phys (1997) 0.86
Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients. Br J Cancer (1993) 0.86
Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancer. Ann Oncol (2000) 0.86
[Trochanteroplasty. Salvage operation in mutilations of the femoral head and neck in children. Indications, technic and results, apropos of 10 cases]. Rev Chir Orthop Reparatrice Appar Mot (1975) 0.86
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]. Cancer Radiother (2011) 0.86
Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial. Cancer Radiother (2010) 0.86
[Tracheobronchial lavage technique using the transnasal route for the detection of Mycoplasma hyopneumoniae in living non-anesthetized swine]. Vet Res (1993) 0.85
Place of radiotherapy in the treatment of Graves' orbitopathy. Int J Radiat Oncol Biol Phys (1999) 0.85
Plasma membrane enzymes in BALB/c lymphomas with either T or B cell properties, I. 5'-Nucleotidase. J Recept Res (1981) 0.85
Dosimetric consequences of breath-hold respiration in conformal radiotherapy of esophageal cancer. Phys Med (2007) 0.85
High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome. Bone Marrow Transplant (1998) 0.84
Treatment duration as a prognostic factor for local control and survival in epidermoid carcinomas of the tonsillar region treated by combined external beam irradiation and brachytherapy. Radiother Oncol (1997) 0.84
Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring. Br J Cancer (1993) 0.84
Rationale for carbon ion therapy in high-grade glioma based on a review and a meta-analysis of neutron beam trials. Cancer Radiother (2009) 0.84
Intensity modulated radiation therapy in head and neck squamous cell carcinoma: state of the art and future challenges. Cancer Radiother (2005) 0.83
Homocystinuria. Trans Am Neurol Assoc (1964) 0.83
Late cardiopulmonary toxicity after treatment for Hodgkin's disease. Br J Cancer (1992) 0.83
Metastatic medulloblastoma: the experience of the French Cooperative M7 Group. Eur J Cancer (1994) 0.83
Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk. Eur J Surg Oncol (2010) 0.83
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC). Int J Cancer (1998) 0.83
Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission. Bone Marrow Transplant (1994) 0.82
[Radiosurgery and brain radio-induced carcinogenesis: update]. Neurochirurgie (2004) 0.82
[Stage I endometrial carcinoma]. Cancer Radiother (2008) 0.82
Effects of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the rat. Free Radic Biol Med (1999) 0.82